1887

Abstract

Tetherin is an interferon-inducible factor that restricts viral particle production. We show here that Sendai virus (SeV) induces a drastic decrease in tetherin levels in infected HeLa cells. Using ectopic expression of tetherin in Madin–Darby canine kidney cells, we find that infectious SeV production is sensitive to restriction by tetherin, suggesting that SeV downregulates tetherin to counter this form of cellular restriction. By using radioactive tetherin in pulse–chase experiments, applying conditions that limit protein degradation, and by estimating tetherin mRNA levels, we find that tetherin degradation is the mechanism of downregulation. Suppression of the virus envelope proteins matrix, fusion (F) or haemagglutinin-neuraminidase protein (HN) during the course of infection demonstrates that F and HN, in concert, are responsible for tetherin degradation. The mechanism(s) by which these two viral glycoproteins participate in degrading tetherin remains to be determined.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.051771-0
2013-06-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/6/1211.html?itemId=/content/journal/jgv/10.1099/vir.0.051771-0&mimeType=html&fmt=ahah

References

  1. Burke E., Dupuy L., Wall C., Barik S.. ( 1998;). Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. . Virology 252:, 137–148. [CrossRef][PubMed]
    [Google Scholar]
  2. Díaz E., Pfeffer S. R.. ( 1998;). TIP47: a cargo selection device for mannose 6-phosphate receptor trafficking. . Cell 93:, 433–443. [CrossRef][PubMed]
    [Google Scholar]
  3. Douglas J. L., Viswanathan K., McCarroll M. N., Gustin J. K., Früh K., Moses A. V.. ( 2009;). Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a betaTrCP-dependent mechanism. . J Virol 83:, 7931–7947. [CrossRef][PubMed]
    [Google Scholar]
  4. Douglas J. L., Gustin J. K., Viswanathan K., Mansouri M., Moses A. V., Früh K.. ( 2010;). The great escape: viral strategies to counter BST-2/tetherin. . PLoS Pathog 6:, e1000913. [CrossRef][PubMed]
    [Google Scholar]
  5. Evans D. T., Serra-Moreno R., Singh R. K., Guatelli J. C.. ( 2010;). BST-2/tetherin: a new component of the innate immune response to enveloped viruses. . Trends Microbiol 18:, 388–396. [CrossRef][PubMed]
    [Google Scholar]
  6. Fouillot-Coriou N., Roux L.. ( 2000;). Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: different role for the two proteins in the production of virus particle. . Virology 270:, 464–475. [CrossRef][PubMed]
    [Google Scholar]
  7. Fritz J. V., Tibroni N., Keppler O. T., Fackler O. T.. ( 2012;). HIV-1 Vpu’s lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin. . Virology 424:, 33–44. [CrossRef][PubMed]
    [Google Scholar]
  8. Ganley I. G., Carroll K., Bittova L., Pfeffer S.. ( 2004;). Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. . Mol Biol Cell 15:, 5420–5430. [CrossRef][PubMed]
    [Google Scholar]
  9. Garcin D., Latorre P., Kolakofsky D.. ( 1999;). Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. . J Virol 73:, 6559–6565.[PubMed]
    [Google Scholar]
  10. Garcin D., Curran J., Itoh M., Kolakofsky D.. ( 2001;). Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. . J Virol 75:, 6800–6807. [CrossRef][PubMed]
    [Google Scholar]
  11. Gosselin-Grenet A. S., Mottet-Osman G., Roux L.. ( 2006;). From assembly to virus particle budding: pertinence of the detergent resistant membranes. . Virology 344:, 296–303. [CrossRef][PubMed]
    [Google Scholar]
  12. Gosselin-Grenet A. S., Mottet-Osman G., Roux L.. ( 2010;). Sendai virus particle production: basic requirements and role of the SYWST motif present in HN cytoplasmic tail. . Virology 405:, 439–447. [CrossRef][PubMed]
    [Google Scholar]
  13. Grigorov B., Rabilloud J., Lawrence P., Gerlier D.. ( 2011;). Rapid titration of measles and other viruses: optimization with determination of replication cycle length. . PLoS ONE 6:, e24135. [CrossRef][PubMed]
    [Google Scholar]
  14. Jia B., Serra-Moreno R., Neidermyer W., Rahmberg A., Mackey J., Fofana I. B., Johnson W. E., Westmoreland S., Evans D. T.. ( 2009;). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. . PLoS Pathog 5:, e1000429. [CrossRef][PubMed]
    [Google Scholar]
  15. Jouvenet N., Neil S. J., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P. D.. ( 2009;). Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. . J Virol 83:, 1837–1844. [CrossRef][PubMed]
    [Google Scholar]
  16. Kupzig S., Korolchuk V., Rollason R., Sugden A., Wilde A., Banting G.. ( 2003;). Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. . Traffic 4:, 694–709. [CrossRef][PubMed]
    [Google Scholar]
  17. Le Tortorec A., Neil S. J.. ( 2009;). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. . J Virol 83:, 11966–11978. [CrossRef][PubMed]
    [Google Scholar]
  18. Lee D. H., Goldberg A. L.. ( 1998;). Proteasome inhibitors: valuable new tools for cell biologists. . Trends Cell Biol 8:, 397–403. [CrossRef][PubMed]
    [Google Scholar]
  19. Mangeat B., Cavagliotti L., Lehmann M., Gers-Huber G., Kaur I., Thomas Y., Kaiser L., Piguet V.. ( 2012;). Influenza virus partially counteracts restriction imposed by tetherin/BST-2. . J Biol Chem 287:, 22015–22029. [CrossRef][PubMed]
    [Google Scholar]
  20. Mansouri M., Viswanathan K., Douglas J. L., Hines J., Gustin J., Moses A. V., Früh K.. ( 2009;). Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi’s sarcoma-associated herpesvirus. . J Virol 83:, 9672–9681. [CrossRef][PubMed]
    [Google Scholar]
  21. Maxfield F. R.. ( 1982;). Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. . J Cell Biol 95:, 676–681. [CrossRef][PubMed]
    [Google Scholar]
  22. Mitchell R. S., Katsura C., Skasko M. A., Fitzpatrick K., Lau D., Ruiz A., Stephens E. B., Margottin-Goguet F., Benarous R., Guatelli J. C.. ( 2009;). Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. . PLoS Pathog 5:, e1000450. [CrossRef][PubMed]
    [Google Scholar]
  23. Mottet G., Portner A., Roux L.. ( 1986;). Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins. . J Virol 59:, 132–141.[PubMed]
    [Google Scholar]
  24. Mottet-Osman G., Iseni F., Pelet T., Wiznerowicz M., Garcin D., Roux L.. ( 2007;). Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. . J Virol 81:, 2861–2868. [CrossRef][PubMed]
    [Google Scholar]
  25. Neil S. J., Zang T., Bieniasz P. D.. ( 2008;). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. . Nature 451:, 425–430. [CrossRef][PubMed]
    [Google Scholar]
  26. Pardieu C., Vigan R., Wilson S. J., Calvi A., Zang T., Bieniasz P., Kellam P., Towers G. J., Neil S. J.. ( 2010;). The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. . PLoS Pathog 6:, e1000843. [CrossRef][PubMed]
    [Google Scholar]
  27. Radoshitzky S. R., Dong L., Chi X., Clester J. C., Retterer C., Spurgers K., Kuhn J. H., Sandwick S., Ruthel G.. & other authors ( 2010;). Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. . J Virol 84:, 10569–10580. [CrossRef][PubMed]
    [Google Scholar]
  28. Rollason R., Korolchuk V., Hamilton C., Schu P., Banting G.. ( 2007;). Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. . J Cell Sci 120:, 3850–3858. [CrossRef][PubMed]
    [Google Scholar]
  29. Roux L., Holland J. J.. ( 1979;). Role of defective interfering particles of Sendai virus in persistent infections. . Virology 93:, 91–103. [CrossRef][PubMed]
    [Google Scholar]
  30. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J.. ( 2009;). Inhibition of Lassa and Marburg virus production by tetherin. . J Virol 83:, 2382–2385. [CrossRef][PubMed]
    [Google Scholar]
  31. Schubert U., Bour S., Ferrer-Montiel A. V., Montal M., Maldarell F., Strebel K.. ( 1996;). The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. . J Virol 70:, 809–819.[PubMed]
    [Google Scholar]
  32. Strahle L., Garcin D., Kolakofsky D.. ( 2006;). Sendai virus defective-interfering genomes and the activation of interferon-beta. . Virology 351:, 101–111. [CrossRef][PubMed]
    [Google Scholar]
  33. Takimoto T., Portner A.. ( 2004;). Molecular mechanism of paramyxovirus budding. . Virus Res 106:, 133–145. [CrossRef][PubMed]
    [Google Scholar]
  34. Weidner J. M., Jiang D., Pan X. B., Chang J., Block T. M., Guo J. T.. ( 2010;). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. . J Virol 84:, 12646–12657. [CrossRef][PubMed]
    [Google Scholar]
  35. Yondola M. A., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P.. ( 2011;). Budding capability of the influenza virus neuraminidase can be modulated by tetherin. . J Virol 85:, 2480–2491. [CrossRef][PubMed]
    [Google Scholar]
  36. Zhang F., Wilson S. J., Landford W. C., Virgen B., Gregory D., Johnson M. C., Munch J., Kirchhoff F., Bieniasz P. D., Hatziioannou T.. ( 2009;). Nef proteins from simian immunodeficiency viruses are tetherin antagonists. . Cell Host Microbe 6:, 54–67. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.051771-0
Loading
/content/journal/jgv/10.1099/vir.0.051771-0
Loading

Data & Media loading...

Supplements

Supplementary material 

PDF

Supplementary material 

PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error